Inventor · disambiguated record
Susan Low
Also filed as: LOW SUSAN · LOW SUSAN C
21 granted patents·12 pending applications·857 citations·filing 2004–2024
96Inventor score
Files withBIOVERATIV THERAPEUTICS INC14LYNDRA THERAPEUTICS INC3SYNTONIX PHARMACEUTICALS INC3BIOGEN HEMOPHILIA INC2DUMONT JENNIFER A2
Top patents by PatentIndex Score
33 records- 0198US7862820B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 4, 2011·120 cites·13 claims
- 0298US7404956B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jul 29, 2008·301 cites·48 claims
- 0398US7348004B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2005·Granted Mar 25, 2008·218 cites·20 claims
- 0496US8329182B2Immunoglobulin chimeric monomer-dimer hybridsPETERS ROBERT T·Filed 2010·Granted Dec 11, 2012·82 cites·38 claims
- 0595US9636416B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted May 2, 2017·20 cites·22 claims
- 0694US11266720B2Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·6 cites·64 claims
- 0794US8932830B2Immunoglobulin chimeric monomer-dimer hybridsBIOGEN IDEC HEMOPHILIA INC·Filed 2012·Granted Jan 13, 2015·25 cites·27 claims
- 0893US10881742B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·5 cites·26 claims
- 0993US9050318B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2010·Granted Jun 9, 2015·28 cites·31 claims
- 1091US10023628B2Cell line expressing single chain factor VIII polypeptides and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Jul 17, 2018·6 cites·17 claims
- 1190US9725496B1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Aug 8, 2017·4 cites·27 claims
- 1290US9241978B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofBIOGEN HEMOPHILIA INC·Filed 2013·Granted Jan 26, 2016·15 cites·21 claims
- 1388US12186375B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·19 claims
- 1487US11168125B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·1 cites·10 claims
- 1586US2025195620A1Factor viii chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1684US12023406B2Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2024·2 cites·57 claims
- 1784US10010622B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2012·Granted Jul 3, 2018·7 cites·22 claims
- 1884US2023023927A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1982US11576866B2Gastric residence systems for sustained delivery of adamantane-class drugsLYNDRA THERAPEUTICS INC·Filed 2017·Granted Feb 14, 2023·5 cites·22 claims
- 2082US9611310B2Systems for factor VIII processing and methods thereofLOW SUSAN C·Filed 2011·Granted Apr 4, 2017·4 cites·25 claims
- 2182US2022010000A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2281US7601516B2Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertilitySYNTOMIX PHARMACEUTICALS INC·Filed 2005·Granted Oct 13, 2009·7 cites·22 claims
- 2377US2022265780A1Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2474US2024382418A1Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2570US11401322B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Aug 2, 2022·0 cites·25 claims
- 2669US2010216804A1Long Circulating Nanoparticles for Sustained Release of Therapeutic AgentsZALE STEPHEN E·Filed 2009·Application pending·0 cites
- 2762US8293707B2Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activityLOW SUSAN C·Filed 2009·Granted Oct 23, 2012·0 cites·19 claims
- 2856US2011217377A1Long Circulating Nanoparticles for Sustained Release of Therapeutic AgentsZALE STEPHEN E·Filed 2011·Application pending·0 cites
- 2955US2019010212A1Cell line expressing single chain factor viii polypeptides and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3054US2016199455A1Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use ThereofBIOGEN HEMOPHILIA INC·Filed 2015·Application pending·0 cites
- 3152US2017267744A1Systems for Factor VIII Processing and Methods ThereofBIOVERATIV THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3246US2021196627A1Systems for enteric delivery of therapeutic agentsLYNDRA INC·Filed 2019·Application pending·0 cites
- 3342US2019099374A1Stable formulations for lyophilizing therapeutic particlesPFIZER·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susan Low files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →